Longitudinal evidence of increasing in vitro tolerance of scabies mites to ivermectin in scabies-endemic communities

Archives of Dermatology

Volumn 145, Issue 7, 2009, Pages 840-841

  Mounsey, Kate E ^a   Holt, Deborah C ^b   McCarthy, James S ^b   Currie, Bart J ^b   Walton, Shelley F ^b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACARICIDE; IVERMECTIN;

CLINICAL ARTICLE; CONTROLLED STUDY; ENDEMIC DISEASE; HUMAN; IN VITRO STUDY; LETTER; NONHUMAN; PRIORITY JOURNAL; SARCOPTES SCABIEI; SCABIES; SKIN DEFECT; SURVIVAL TIME;

ANIMALS; ANTIPARASITIC AGENTS; DRUG RESISTANCE; ENDEMIC DISEASES; HUMANS; IVERMECTIN; SARCOPTES SCABIEI; SCABIES;

EID: 67650802501     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2009.125     Document Type: Letter

References (5)

1. Carapetis JR, Currie BJ. Group A streptococcus, pyoderma, and rheumatic fever. Lancet. 1996;347(9010):1271-1272.
2. Currie BJ, Harumal P, McKinnon M, Walton SF. First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clin Infect Dis. 2004;39(1):e8-e12.
3. Walton SF, McKinnon M, Pizzutto S, Dougall A, Williams E, Currie BJ. Acaricidal activity of Melaleuca alternifolia (tea tree) oil: in vitro sensitivity of Sarcoptes scabiei var hominis to terpinen-4-ol. Arch Dermatol. 2004;140(5):563-566.
4. Currie BJ, Connors C, Krause V. Scabies programs in Aboriginal communities. Med J Aust. 1994;161(10):636-637.
5. Currie BJ, Carapetis JR. Skin infections and infestations in Aboriginal communities in northern Australia. Australas J Dermatol. 2000;41(3):139-145.